Literature DB >> 11401190

Simvastatin-associated memory loss.

A Orsi1, O Sherman, Z Woldeselassie.   

Abstract

The statins are widely used to treat dyslipidemias. They are generally associated with mild adverse effects, but rarely, more serious reactions may occur. A 51-year-old man experienced delayed-onset, progressive memory loss while receiving simvastatin for hypercholesterolemia. His therapy was switched to pravastatin, and memory loss resolved gradually over the next month, with no recurrence of the adverse effect.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11401190     DOI: 10.1592/phco.21.7.767.34577

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  33 in total

1.  Transient global amnesia associated with statin intake.

Authors:  David Healy; Roger Morgan; Srinivasan Chinnaswamy
Journal:  BMJ Case Rep       Date:  2009-02-26

Review 2.  Current drug treatment of hyperlipidemia in older adults.

Authors:  Dave L Dixon; Krista L Donohoe; Kelechi C Ogbonna; Sarah M Barden
Journal:  Drugs Aging       Date:  2015-02       Impact factor: 3.923

Review 3.  Cognitive effects of statin medications.

Authors:  Brendan J Kelley; Stephen Glasser
Journal:  CNS Drugs       Date:  2014-05       Impact factor: 5.749

4.  PCSK9 Variants, Low-Density Lipoprotein Cholesterol, and Neurocognitive Impairment: Reasons for Geographic and Racial Differences in Stroke Study (REGARDS).

Authors:  Matthew T Mefford; Robert S Rosenson; Mary Cushman; Michael E Farkouh; Leslie A McClure; Virginia G Wadley; Marguerite R Irvin; Vera Bittner; Monika M Safford; Ransi Somaratne; Keri L Monda; Paul Muntner; Emily B Levitan
Journal:  Circulation       Date:  2017-11-16       Impact factor: 29.690

5.  Altered Cholesterol Intracellular Trafficking and the Development of Pathological Hallmarks of Sporadic AD.

Authors:  Xuesong Chen; Liang Hui; Mahmoud L Soliman; Jonathan D Geiger
Journal:  J Parkinsons Dis Alzheimers Dis       Date:  2014

6.  Role of endolysosomes and cholesterol in the pathogenesis of Alzheimer's disease: Insights into why statins might not provide clinical benefit.

Authors:  Xuesong Chen; Liang Hui; Jonathan D Geiger
Journal:  Austin J Pharmacol Ther       Date:  2014-08-26

Review 7.  Blood Pressure and Statin Effects on Cognition: a Review.

Authors:  Mia Yang; Jeff Williamson
Journal:  Curr Hypertens Rep       Date:  2019-07-26       Impact factor: 5.369

Review 8.  Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management.

Authors:  Marco Tuccori; Sabrina Montagnani; Stefania Mantarro; Alice Capogrosso-Sansone; Elisa Ruggiero; Alessandra Saporiti; Luca Antonioli; Matteo Fornai; Corrado Blandizzi
Journal:  CNS Drugs       Date:  2014-03       Impact factor: 5.749

9.  Association of statin use with cognitive decline in elderly African Americans.

Authors:  S J Szwast; H C Hendrie; K A Lane; S Gao; S E Taylor; F Unverzagt; J Murrell; M Deeg; A Ogunniyi; M R Farlow; K S Hall
Journal:  Neurology       Date:  2007-11-06       Impact factor: 9.910

10.  Effects of atorvastatin on higher functions.

Authors:  G P Parale; N N Baheti; P M Kulkarni; N V Panchal
Journal:  Eur J Clin Pharmacol       Date:  2006-02-18       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.